latest news releases from the newsroom
InnovationsKapital Invests in Visual Wireless
STOCKHOLM, Sweden, May 16, 2002 (PRIMEZONE) -- InnovationsKapital has signed an agreement to invest in the Swedish IT company Visual Wireless. This investment makes InnovationsKapital one of the three largest owners of Visual Wireless. In addition to the financial resources, InnovationsKapital brings to Visual Wireless a breadth of experience that will be very significant in Visual Wireless's continued international expansion.
Hermes Epitek to Distribute and Service Micronic's Products in Taiwan and Southeast Asia Region
TABY, Sweden, May 16, 2002 (PRIMEZONE) -- Micronic Laser Systems AB (OM Stockholm Exchange: MICR), a leading manufacturer of laser pattern generation equipment to semiconductor and display industries, today announced that it has partnered with Hermes Epitek, a top-tier Taiwanese representative to semiconductor equipment and materials firms. Hermes will handle Micronic's sales and service support functions in Taiwan and the Southeast Asia region.
Telia is Not Granted Inhibition in Case Against Tele2 Regarding Interconnect Rates
NEW YORK and STOCKHOLM, Sweden, May 16, 2002 (PRIMEZONE) -- Tele2 AB, ("Tele2," "the Group") (Nasdaq:TLTOA) (Nasdaq:TLTOB) (Stockholmsborsen: TEL2A) (Stockholmsborsen:TEL2B), the leading alternative pan-European telecommunications company, today announces that the Swedish Administrative Court of Appeal has decided not to grant inhibition of the Stockholm County Administrative Court's ruling in the case against Telia regarding payment principles for interconnection. The decision was that Telia is liable for payments regarding traffic transited via their network ("Cascade Accounting") at certain tariff rates.
Head N.V.: Results for the Three Months Ended March 31, 2002
ROTTERDAM, The Netherlands, May 16, 2002 (PRIMEZONE) -- Head N.V. (NYSE:HED) (VSX:HEAD), a leading global manufacturer and marketer of sports equipment, announced today revenues of $74.9 million for the three months ended March 31, 2002. Excluding 2001 sales of footwear, which beginning January 2002 is a licensed product, revenues were up 2.1% from the same period last year and at constant currency revenues were up 6.2%. For the period Head's operating result improved by $1.2 million from a loss of $3.1 million in the first quarter of 2001 to loss of $1.9 million in the same period in 2002. Due to a $4.7 million foreign exchange gain in the first quarter of 2001 versus $0.3 million in 2002, the loss per share for the three month period was $0.09 compared to $0.04 for the same period in 2001.
Karo Bio's Capital Markets Day in London
HUDDINGE, Sweden, May 16, 2002 (PRIMEZONE) -- Karo Bio, a leading international drug discovery company focusing on nuclear receptors as drug targets, will today present an overview of the Company for investors and analysts at a Capital Markets Day in London. The management team, led by President Bjorn Nilsson, will summarize Karo Bio's business and financial strategies as well as updating investors and analysts on progress in the Company's product pipeline and key technologies.
Important Decision Upholds Class Action Against Mylan -- MYL
NEW YORK, May 15, 2002 (PRIMEZONE) -- The United States Court of Appeals for the District of Columbia Circuit on May 14, 2002 issued an important decision upholding the certification of a nationwide class action on behalf of all direct purchasers of two widely prescribed generic drugs, lorazepam and clorazepate, against defendants Mylan Laboratories, Inc. (NYSE:MYL) and Mylan Pharmaceuticals, Inc. ("Mylan"). The decision denied a petition to appeal by Mylan. A copy of the decision in the In re Lorazepam and Clorazepate Antitrust Litigation is faxed herewith.